Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Syndax Pharmaceuticals (SNDX) Interest Coverage Ratio (2020 - 2025)

Syndax Pharmaceuticals has reported Interest Coverage Ratio over the past 6 years, most recently at 17338.25 for Q2 2025.

  • For Q2 2025, Interest Coverage Ratio fell 951.28% year-over-year to 17338.25; the TTM value through Mar 2026 reached 55882.25, down 977.44%, while the annual FY2025 figure was 45514.0, 113.4% down from the prior year.
  • Interest Coverage Ratio for Q2 2025 was 17338.25 at Syndax Pharmaceuticals, up from 41878.5 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 777.14 in Q4 2024 and troughed at 41878.5 in Q1 2025.
  • A 5-year average of 4689.19 and a median of 945.73 in 2022 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: plummeted 43635.16% in 2021 and later soared 162.85% in 2024.
  • Year by year, Interest Coverage Ratio stood at 13678.43 in 2021, then soared by 92.85% to 977.51 in 2022, then decreased by 26.5% to 1236.59 in 2023, then soared by 162.85% to 777.14 in 2024, then tumbled by 2331.04% to 17338.25 in 2025.
  • Business Quant data shows Interest Coverage Ratio for SNDX at 17338.25 in Q2 2025, 41878.5 in Q1 2025, and 777.14 in Q4 2024.